Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid DNA nanoparticles

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 1095-1102

  Zhu, Dunwan ^a   Jin, Xu ^b   Leng, Xigang ^a   Wang, Hai ^a   Bao, Junbo ^a   Liu, Wenguang ^c   Yao, Kangde ^c   Song, Cunxian ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TIANJIN UNIVERSITY   (China)

Author keywords

Chitosan; Endovascular stent; Gene delivery; Gene nanoparticles

Indexed keywords

CHITOSAN; DNA NANOPARTICLE; NANOPARTICLE; PLASMID DNA; UNCLASSIFIED DRUG; CIRCULAR DNA; PHOTOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR GENE THERAPY; CELL CULTURE; CONTROLLED STUDY; CORONARY STENT; GENE ACTIVITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; IN-STENT RESTENOSIS; MATERIAL COATING; NONHUMAN; RABBIT; RAT; REPORTER GENE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL; AGAR GEL ELECTROPHORESIS; ANIMAL; BLOOD VESSEL PROSTHESIS; CHEMISTRY; COMMON CAROTID ARTERY; DRUG ELUTING STENT; GENE TRANSFER; GENETIC TRANSFECTION; METABOLISM; PARTICLE SIZE; PLASMID;

ANIMALIA;

ANIMALS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERY, COMMON; CHITOSAN; DNA, CIRCULAR; DRUG-ELUTING STENTS; ELECTROPHORESIS, AGAR GEL; GENE TRANSFER TECHNIQUES; LUMINESCENT PROTEINS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PLASMIDS; RABBITS; TRANSFECTION;

EID: 79954472675     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S14358     Document Type: Article

References (19)

1. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation. 2000;102(24): 2945-2951.
2. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872-1878.
3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331(8):496-501.
4. Serruys PW, Foley DP, Suttorp MJ, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol. 2002;39(3):393-399.
5. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part I. Circulation. 2002;106(21):2734-2740.
6. Farb A, Boam AB. Stent thrombosis redux-the FDA perspective. N Engl J Med. 2007;356(10):984-987.
7. Levy RJ, Song C, Tallapragada S, et al. Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther. 2001;8(9): 659-667.
8. Sharif F, Daly K, Crowley J, O'Brien T. Current status of catheter- and stent-based gene therapy. Cardiovasc Res. 2004;64(2):208-216.
9. Jin X, Mei L, Song C, et al. Immobilization of plasmid DNA on an anti- DNA antibody modified coronary stent for intravascular site-specific gene therapy. J Gene Med. 2008;10(4):421-429.
10. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med. 1999;5(4):387-391.
11. Liu WG, Zhang X, Sun SJ, et al. N-alkylated chitosan as a potential nonviral vector for gene transfection. Bioconjug Chem. 2003;14(4): 782-789.
12. Li F, Liu WG, Yao KD. Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. Biomaterials. 2002;23(2):343-347.
13. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70(3):399-421.
14. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled- release stent in porcine coronary arteries. Nat Biotechnol. 2000; 18(11):1181-1184.
15. Klugherz BD, Song C, DeFelice S, et al. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther. 2002;13(3):443-454.
16. Westedt U, Barbu-Tudoran L, Schaper AK, Kalinowski M, Alfke H, Kissel T. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS Pharm Sci. 2002;4(4):E41.
17. Gradus-Pizlo I, Wilensky RL, March KL, et al. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. J Am Coll Cardiol. 1995;26(6):1549-1557.
18. Dev V, Eigler N, Fishbein MC, et al. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Cathet Cardiovasc Diagn. 1997;41(3):324-332.
19. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release. 1998;53(1-3):183-193.